{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:55:34Z","timestamp":1772578534446,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04234-7","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T10:55:32Z","timestamp":1745060132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and efficacy of Simvastatin in the treatment of vitiligo: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"317","author":[{"given":"Song","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Serag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen Mohamed","family":"Olama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud G. A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Shaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa Hossam El Din","family":"Moawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"4234_CR1","unstructured":"Ahmed Jan N, Masood S (2025) Vitiligo. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"4234_CR2","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1304s2a312s","author":"J Seneschal","year":"2023","unstructured":"Seneschal J (2023) Clinical features of vitiligo and social impact on quality of life. Dermatol Pract Concept. https:\/\/doi.org\/10.5826\/dpc.1304s2a312s","journal-title":"Dermatol Pract Concept."},{"issue":"2","key":"4234_CR3","first-page":"167","volume":"5","author":"HA Al-Shobaili","year":"2011","unstructured":"Al-Shobaili HA (2011) Update on the genetics characterization of vitiligo. Int J Health Sci (Qassim) 5(2):167\u2013179","journal-title":"Int J Health Sci (Qassim)"},{"issue":"1","key":"4234_CR4","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","volume":"4","author":"M Picardo","year":"2015","unstructured":"Picardo M, Dell\u2019Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D et al (2015) Vitiligo. Nat Rev Dis Primers 4(1):15011","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"4234_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fendo.2017.00290","volume":"27","author":"E Baldini","year":"2017","unstructured":"Baldini E, Odorisio T, Sorrenti S, Catania A, Tartaglia F, Carbotta G et al (2017) Vitiligo and autoimmune thyroid disorders. Front Endocrinol (Lausanne) 27(8):290","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"4234_CR6","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","volume":"25","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CCE et al (2012) Revised classification\/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference. Pigment Cell Melanoma Res 25(3):E1-13","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"4234_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/0974-2077.112667","volume":"6","author":"K Sahni","year":"2013","unstructured":"Sahni K, Parsad D (2013) Stability in vitiligo: is there a perfect way to predict it? J Cutan Aesthet Surg 6(2):75\u201382","journal-title":"J Cutan Aesthet Surg"},{"issue":"13","key":"4234_CR8","doi-asserted-by":"publisher","first-page":"986918","DOI":"10.3389\/fimmu.2022.986918","volume":"31","author":"Y Feng","year":"2022","unstructured":"Feng Y, Lu Y (2022) Advances in vitiligo: update on therapeutic targets. Front Immunol 31(13):986918","journal-title":"Front Immunol"},{"issue":"9","key":"4234_CR9","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s13555-023-00983-3","volume":"13","author":"D Rosmarin","year":"2023","unstructured":"Rosmarin D, Soliman AM, Li C (2023) Real-world treatment patterns in patients with vitiligo in the United States. Dermatol Ther (Heidelb) 13(9):2079\u20132091","journal-title":"Dermatol Ther (Heidelb)"},{"key":"4234_CR10","unstructured":"Bansal AB, Cassagnol M (2025) HMG-CoA reductase inhibitors. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"issue":"10","key":"4234_CR11","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1111\/ijd.15330","volume":"60","author":"R Hasan","year":"2021","unstructured":"Hasan R, Agarwal K, Podder I, Misitzis A, Schwartz RA, Wollina U et al (2021) Simvastatin in vitiligo: an update with recent review of the literature. Int J Dermatol 60(10):e390\u2013e396","journal-title":"Int J Dermatol"},{"issue":"13","key":"4234_CR12","doi-asserted-by":"publisher","first-page":"1055958","DOI":"10.3389\/fimmu.2022.1055958","volume":"10","author":"C Lyu","year":"2022","unstructured":"Lyu C, Sun Y (2022) Immunometabolism in the pathogenesis of vitiligo. Front Immunol 10(13):1055958","journal-title":"Front Immunol"},{"issue":"1","key":"4234_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1152\/physrev.00045.2020","volume":"102","author":"E Crosas-Molist","year":"2022","unstructured":"Crosas-Molist E, Samain R, Kohlhammer L, Orgaz JL, George SL, Maiques O et al (2022) Rho GTPase signaling in cancer progression and dissemination. Physiol Rev 102(1):455\u2013510","journal-title":"Physiol Rev"},{"issue":"3","key":"4234_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/jewd.jewd_93_23","volume":"21","author":"SI Omar","year":"2024","unstructured":"Omar SI, El Shafey A, Eldabah N, Hafez A (2024) A comparative study of narrow-band ultraviolet B alone versus with low dose simvastatin in the treatment of vitiligo: impact on chemokine C-X-C motif ligand 10 and chemokine C-C motif ligand 8. J Egypt Womens Dermatol Soc 21(3):213\u2013221","journal-title":"J Egypt Womens Dermatol Soc"},{"issue":"1","key":"4234_CR15","doi-asserted-by":"publisher","first-page":"14612","DOI":"10.1038\/s41598-024-65722-w","volume":"14","author":"A Niezgoda","year":"2024","unstructured":"Niezgoda A, Winnicki A, Krysi\u0144ski J, Niezgoda P, Nowowiejska L, Czajkowski R (2024) Topical application of simvastatin acid sodium salt and atorvastatin calcium salt in vitiligo patients. Results of the randomized, double-blind EVRAAS pilot study. Sci Rep 14(1):14612","journal-title":"Sci Rep"},{"key":"4234_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13175225","author":"R Speeckaert","year":"2024","unstructured":"Speeckaert R, Caelenberg EV, Belpaire A, Speeckaert MM, van Geel N (2024) Vitiligo: from pathogenesis to treatment. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13175225","journal-title":"J Clin Med"},{"issue":"4","key":"4234_CR17","doi-asserted-by":"publisher","first-page":"L575","DOI":"10.1152\/ajplung.00428.2007","volume":"295","author":"W Chen","year":"2008","unstructured":"Chen W, Pendyala S, Natarajan V, Garcia JGN, Jacobson JR (2008) Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition. Am J Physiol Lung Cell Mol Physiol 295(4):L575\u2013L583","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4234_CR18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"M Page","year":"2021","unstructured":"Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"366","key":"4234_CR19","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 28(366):l4898","journal-title":"BMJ"},{"issue":"12","key":"4234_CR20","doi-asserted-by":"publisher","first-page":"e15969","DOI":"10.1111\/dth.15969","volume":"35","author":"ESE Shaker","year":"2022","unstructured":"Shaker ESE, Allam SH, Mabrouk MM, Elgharbawy NM, Salaam SFA (2022) Simvastatin and non-segmental vitiligo: a new potential treatment option? Dermatol Ther 35(12):e15969","journal-title":"Dermatol Ther"},{"key":"4234_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168820","author":"A D\u2019Arino","year":"2021","unstructured":"D\u2019Arino A, Picardo M, Truglio M, Pacifico A, Iacovelli P (2021) Metabolic comorbidities in vitiligo: a brief review and report of new data from a single-center experience. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22168820","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4234_CR22","first-page":"e14029","volume":"13","author":"D Verma","year":"2021","unstructured":"Verma D, Hussain K, Namiq KS, Firoz A, Bouchama M, Raza M et al (2021) Vitiligo: the association with metabolic syndrome and the role of simvastatin as an immunomodulator. Cureus 13(3):e14029","journal-title":"Cureus"},{"issue":"3","key":"4234_CR23","doi-asserted-by":"publisher","first-page":"e13642","DOI":"10.1111\/srt.13642","volume":"30","author":"A Jafarzadeh","year":"2024","unstructured":"Jafarzadeh A, Pour Mohammad A, Khosravi M, Amiri S, Rasouli A, Keramati H et al (2024) A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo. Skin Res Technol 30(3):e13642","journal-title":"Skin Res Technol"},{"issue":"2","key":"4234_CR24","doi-asserted-by":"publisher","first-page":"e16660","DOI":"10.1111\/jocd.16660","volume":"24","author":"A Jafarzadeh","year":"2025","unstructured":"Jafarzadeh A, Mohammad AP, Goodarzi A (2025) A systematic review of case series and clinical trials investigating regenerative medicine for the treatment of vitiligo. J Cosmet Dermatol 24(2):e16660","journal-title":"J Cosmet Dermatol"},{"key":"4234_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01675-4","author":"A Jafarzadeh","year":"2025","unstructured":"Jafarzadeh A, Behrangi E, Khosravi M, Falakeh S, Amiri JK, Goodarzi A (2025) Emerging treatments for dermatologic diseases in infants, children, and adolescents: a systematic review of clinical trials on biologics and small molecule inhibitors. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-025-01675-4","journal-title":"Inflammopharmacology"},{"issue":"1","key":"4234_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10103-024-04259-w","volume":"40","author":"N Atefi","year":"2025","unstructured":"Atefi N, Yeganeh ZP, Bazargan AS, Yeganeh MSP, Jafarzadeh A, Zare M et al (2025) Evaluation of the efficacy, safety, and satisfaction rate of topical latanoprost in patients with hypopigmented burn scars treated with fractional CO2 laser: a double-blind randomized controlled clinical trial. Lasers Med Sci 40(1):14","journal-title":"Lasers Med Sci"},{"issue":"1","key":"4234_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/TJD.TJD_38_19","volume":"14","author":"H Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy H, Hussian N, Al-Naimi M, Al-Gareeb A (2020) Statins role in vitiligo: a mini-review. Turk J Dermatol 14(1):1","journal-title":"Turk J Dermatol"},{"issue":"6","key":"4234_CR28","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/jocd.16227","volume":"23","author":"H Zartab","year":"2024","unstructured":"Zartab H, Aflatoonian M, Shamsi-Meymandi S, Pardakhty A, Isazadeh A, Firooz A et al (2024) Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non-segmental vitiligo. J Cosmet Dermatol 23(6):2103\u20132108","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"4234_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/tpj.2015.91","volume":"16","author":"T Duarte","year":"2016","unstructured":"Duarte T, da Cruz IBM, Barbisan F, Capelleto D, Moresco RN, Duarte MMMF (2016) The effects of rosuvastatin on lipid-lowering, inflammatory, antioxidant and fibrinolytics blood biomarkers are influenced by Val16Ala superoxide dismutase manganese-dependent gene polymorphism. Pharmacogenomics J 16(6):501\u2013506","journal-title":"Pharmacogenomics J"},{"key":"4234_CR30","doi-asserted-by":"publisher","DOI":"10.5812\/jkums-143510","author":"L Dastgheib","year":"2024","unstructured":"Dastgheib L, Salehi Rad K, Cheshmeh Ghasabani H, Sadati MS (2024) The efficacy of combined \u201coral simvastatin plus narrowband UVB phototherapy\u201d than \u201cphototherapy alone\u201d in treating skin lesions in patients with vitiligo, a double-blind add-on randomized controlled clinical trial. J Kermanshah Univ Med Sci. https:\/\/doi.org\/10.5812\/jkums-143510","journal-title":"J Kermanshah Univ Med Sci."},{"key":"4234_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/2277-9175.203159","volume":"6","author":"F Iraji","year":"2017","unstructured":"Iraji F, Banihashemi SH, Faghihi G, Shahmoradi Z, Tajmirriahi N, Jazi SB (2017) A comparison of betamethasone valerate 0.1% cream twice daily plus oral simvastatin versus betamethasone valerate 0.1% cream alone in the treatment of vitiligo patients. J Adv Biomed Res. 6:34","journal-title":"J Adv Biomed Res."},{"issue":"1","key":"4234_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaad.2016.06.015","volume":"76","author":"SG Vanderweil","year":"2017","unstructured":"Vanderweil SG, Amano S, Ko W-C, Richmond JM, Kelley M, Senna MM et al (2017) A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo. J Am Acad Dermatol 76(1):150-151.e3","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04234-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04234-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04234-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T10:55:33Z","timestamp":1745060133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04234-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4234"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04234-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable and all data are available on the internet.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"726"}}